A single-cell survey of cellular hierarchy in acute myeloid leukemia | Journal of Hematology & Oncology | Full Text
AML, NOS and AML-MRC as defined by multilineage dysplasia share a common mutation pattern which is distinct from AML-MRC as defined by MDS-related cytogenetics | Leukemia
Characterization and Prognosis of Secondary Acute Myeloid Leukemia in an Asian Population: AML With Antecedent Hematological Disease Confers Worst Outcomes, Irrespective of Cytogenetic Risk | Anticancer Research
Effect of therapy-related acute myeloid leukemia on the outcome of patients with acute myeloid leukemia
Common mutations in de novo and secondary AML. A number of clonal blood... | Download Scientific Diagram
Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06 | Haematologica
Recurrent mutation groups in de novo AML. Genes recurrently mutated in... | Download Scientific Diagram
High efficacy of Azacitidine plus HAG in acute myeloid leukemia: an open-label, single-arm, multi-center, phase 2 study | Blood Cancer Journal
Venetoclax plus intensive induction chemotherapy safe for fit, older patients with AML
Survival of de novo acute myeloid leukemia at MD Anderson (1970-2017)... | Download Scientific Diagram
A) Incidence of De Novo, Secondary, and Therapy-Related Acute Myeloid... | Download Scientific Diagram
Recently approved therapies in acute myeloid leukemia: A complex treatment landscape - ScienceDirect
IJMS | Free Full-Text | Application of High Throughput Technologies in the Development of Acute Myeloid Leukemia Therapy: Challenges and Progress
Haematologica August 2021
Acute Myeloid Leukemia | Oncohema Key
JCM | Free Full-Text | Revealing the Mysteries of Acute Myeloid Leukemia: From Quantitative PCR through Next-Generation Sequencing and Systemic Metabolomic Profiling
How do doctors tell de novo acute myeloid leukemia (de novo AML), AML-MRC, and tAML apart? - YouTube
Biology of secondary leukemia
Outcome of patients with either de novo or secondary AML after alloSCT... | Download Scientific Diagram
Key Topic Videos | MYLOTARG®▽(gemtuzumab ozogamicin) | PfizerPro UK
Mutational variation in de-novo and secondary acute myeloid Leukemia.... | Download Scientific Diagram
Personalizing initial therapy in acute myeloid leukemia: incorporating novel agents into clinical practice - Christin B. DeStefano, Christopher S. Hourigan, 2018
Frontiers | Drug Resistance Mechanisms of Acute Myeloid Leukemia Stem Cells
Genes | Free Full-Text | Genetic and Genomic Landscape of Secondary and Therapy-Related Acute Myeloid Leukemia
SocforHemepath on Twitter: "Another new provisional entity in the 2017 WHO: Acute Myeloid Leukemia with BCR-ABL1. This is a type of de novo AML, not to be confused with the blast phase
